Human T-cell lymphotrophic virus type I (HTLV-I) is the aetiological agent of adult T-cell leukemia (ATL) and tropical spastic paraparesis/HTLV-associated myelopathy (TSP/HAM). It is endemic in Japan, the Caribbean basin and Africa. Unlike HTLV-I, HTLV-II, a closely related retrovirus, has not been formally linked with any disease and its epidemiology has not been established yet. HTLV-II has been observed in a high prevalence among US and European injecting drug users, and among certain Amerindian tribes. A number of studies have pointed out that HTLV-I is widespread in Africa and HTLV-II is also present but with a lower prevalence in that continent. ' In a previous report,2 we HIV, the other six being also homosexual men. Thirtythree (89%) of the control group were homosexual men, two were African, one was the heterosexual partner of an HIV positive woman, and for one there was no clear risk factor. Thirteen of the drug users were receiving opiates on a legal prescription, 13 were using non-prescribed opiates and 11 were former drug users. Seven of the IDUs were noted to have significant alcohol problems, compared with none of the control group: this may have been an artefact of recording. Eleven (30%) of the IDUs were without permanent housing, compared with two of the control group (X2 = 5-97, p = 0.014).
There was no difference in the number of admissions per patient during the study period ( 
